H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Cassava Sciences (SAVA – Research Report) yesterday and set a price target of $124.00. The company's shares closed last Thursday at $17.16, close to its 52-week low of $13.84. According to TipRanks.com, Bernardino is a 5-star analyst with an average return of 24.7% and a 36.0% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Eledon Pharmaceuticals, Aridis Pharmaceuticals, and Achieve Life Sciences. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cassava Sciences with a $72.50 average price target, implying a 281.6% upside from current levels.
https://www.tipranks.com/news/blurbs/h-c-wainwright-thinks-cassava-sciences-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Cassava Sciences Charts.